EPSRC - Centre for Innovative Manufacturing in Regenerative Medicine

Ways of working with us

The EPSRC Centre works with a wide range of academic, clinical and industrial partners, however we seek to develop new collaborative and contract research opportunities with interested parties.

Potential collaborators are welcome to contact us with details of the research and/or engagement activity of interest.

 

Collaborative research

We collaborate with academic, clinical and commercial organisations on a wide range of funded research, both within our existing EPSRC Centre funding and in applying for new funding for co-designed projects. We are building a pre-competitive community of practice to share best practice in regenerative medicine manufacturing. Cost-effective ways of working with us include part- or fully-sponsoring a PhD studentship.

  • Case study 1 – HypoxyCOOLTM with Ruskinn Technology Ltd
  • Case study 2 – Blood pharma – a pipeline of collaborative projects

Contract research

Colleagues within the EPSRC Centre are available to work on confidential research projects for commercial clients. Businesses can commission the Centre’s researchers to work on problems specific to their needs.

  • Case study 3 – ReNeuron project with the Cell Therapy Catapult

Facilities and services

Each of the universities within the EPSRC Centre has cutting edge facilities available for working with collaborators including quality-managed biological engineering laboratories, advanced manufacturing workshops and analytical measurement suites.

Knowledge Transfer Partnerships (KTPs)

KTPs are relationships formed between a commercial organisation and a university, facilitating the transfer of knowledge, technology and skills to which the commercial partner currently has no access. Projects can vary in length from 6 to 36 months and support can be provided in preparing the funding application.

  • Case study 4 - Knowledge Transfer Partnership with TAP Biosystems

Investment and licensing

Opportunities arise from time to time for tools and technologies to be licensed to commercial organisations or for spin-out companies to be created. Potential investors or licensees are invited to contact us.